Prognostic significance of body mass index and other tumor and patient characteristics in non-metastatic renal cell carcinoma

Vusal Ahmedov, Fuat K?z?lay, ?brahim Cüreklibat?r

Abstract


276

Purpose: In this retrospective study, we aimed to investigate the prognostic effect of body mass index (BMI) in localized renal cell carcinoma (RCC) cases who underwent surgical treatment. Furthermore, the assessment of various patient and tumor characteristics and surgical methods on survival has been identified as additional targets.
Materials and Methods: Three hundred and eighty patients with localised, non-metastatic, unilateral RCC who underwent radical or partial nephrectomy in our clinic between January 2007 and December 2016 were enrolled in this study. Age, gender, height, weight, BMI, operation type and method, pathology results and tumor stage of the patients were recorded. Patients were divided into 3 groups according to body mass index (BMI): Normal weight
(< 25 kg/m2), overweight (25-30 kg/m2) and obese (>30 kg/m2) as groups 1, 2 and 3, respectively. We analyzed the relation between the BMI, gender, smoking, hypertension, type and method of surgical treatment, histologic subtype, tumor stage, estimated glomerular filtration rate (eGFR) and cancer-specific (CSS) and recurrence free survival (RFS). All data analysis was performed using SPSS® Statistical Software for Windows (Version 13.0) and a P value less than 0.05 was considered to be significant.
Results: The effect of BMI on both CSS and RFS was statistically significant (P < .001). There was also a significant relation between smoking, operation type (partial/radical), eGFR and tumor stage and CSS and RFS.
Conclusion: Our findings show that overweight and obese RCC patients according to the BMI have a more favorable
prognosis. Multicenter, prospective studies with more cases and longer oncological follow-up period are needed to support these findings.

Full Text:

PDF

112

References


Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007; 18: 581-92.

Rodriguez-Covarrubias F, Gomez-Alvarado MO, Sotomayor M, et al. Time to Recurrence after Nephrectomy as a Predictor of Cancer-Specific Survival in Localized Clear-Cell Renal Cell Carcinoma. Urol Int. 2011; 86: 47-52.

Parker WP, Cheville JC, Frank I, et al. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal

Cell Carcinoma in Contemporary Patients. Eur Urol. 2017; 71: 665-73.

de Velasco G, Culhane AC, Fay AP, et al. Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell

Carcinoma Database Consortium Prognostic Model. Oncologist. 2017; 22: 286-92.

Karakiewicz PI, Suardi N, Capitanio U, et al. A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol. 2009; 55: 287-95.

Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2006; 118: 728-38.

Weikert S, Boeing H, Pischon T, et al. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2007; 167: 438-46.

Patard JJ, Rodriguez A, Rioux‐Leclercq N, Guille F, Lobel B. Prognostic significance of the mode of detection in renal tumours. BJU Int. 2002; 90: 358-63.

Donat SM, Salzhauer EW, Mitra N, Yanke BV, Snyder ME, Russo P. Impact of body mass index on survival of patients with

surgically treated renal cell carcinoma. J. urol. 2006; 175: 46-52.

Kamat AM, Shock RP, Naya Y, Rosser CJ, Slaton JW, Pisters LL. Prognostic value of body mass index in patients undergoing

nephrectomy for localized renal tumors. Urology. 2004; 63: 46-50.

Sobin L, Gospodarowicz M. Wittekind Ch. Eds. TNM Classification of Malignant Tumors: wiley-blackwell, Oxford; 2009.

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999; 130: 461-70.

Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015; 67: 913-24.

Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014; 311: 806-14.

Bergström A, Hsieh C, Lindblad P, Lu C, Cook N, Wolk A. Obesity and renal cell cancer–a quantitative review. Br J Cancer. 2001; 85:984.

Drabkin HA, Gemmill RM. Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC). Adv Cancer Res. 2010; 107: 39-56.

Scacchi M, Pincelli A, Cavagnini F. Growth hormone in obesity. Int J Obes. 1999; 23: 260-71.

Hodgson AV, Ayala-Torres S, Thompson EB, Liehr JG. Estrogen-induced microsatellite DNA alterations are associated with Syrian hamster kidney tumorigenesis. Carcinogenesis.

; 19: 2169-72.

Gago-Dominguez M, Castelao JE, Yuan J-M, Ross RK, Mimi CY. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control. 2002; 13: 287-93.

Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ. 2007; 335:1134.

Jeon HG, Jeong IG, Lee JH, et al. Prognostic value of body mass index in Korean patients with renal cell carcinoma. J. urol. 2010; 183:448-54.

Morgan TM, Tang D, Stratton KL, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol. 2011; 59: 923-8.

Nomiya T, Tsuji H. Renal Cell Carcinoma. Carbon-Ion Radiotherapy: Springer; 2014:241-9.

Sahin H, Sahin H. Reasons for not using family planning methods in Eastern Turkey. The European Journal of Contraception & Reproductive Health Care. 2003; 8: 11-6.

Shapiro JA, Williams MA, Weiss NS, Stergachis A, LaCroix AZ, Barlow WE. Hypertension, antihypertensive medication

use, and risk of renal cell carcinoma. Am J Epidemiol. 1999; 149: 521-30.

Pettus JA, Jang TL, Thompson RH, Yossepowitch O, Kagiwada M, Russo P. Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors. Paper presented at: Mayo Clinic Proceedings,

Thompson RH, Raj GV, Leibovich BC, Russo P, Blute ML, Kattan MW. Preoperative nomogram to predict positive lymph nodes during nephrectomy for renal cell carcinoma. J. urol. 2008; 179:212.

Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic

classification and revised TNM staging system of renal cell carcinoma. Cancer. 2000;89: 604-14.

Beck SD, Patel MI, Snyder ME, et al. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma. Ann Surg Oncol. 2004;

: 71-7.

Brierley JD. TNM classification of malignant tumours: John Wiley & Sons; 2017.




DOI: http://dx.doi.org/10.22037/uj.v0i0.4067


Creative Commons License 
This work is licensed under a Creative Commons Attribution 3.0 License